Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Ordinary Shares, $0.0001 par value
-
Shares outstanding
-
173M
-
Number of holders
-
150
-
Total 13F shares, excl. options
-
55.9M
-
Shares change
-
-4.72M
-
Total reported value, excl. options
-
$981M
-
Value change
-
-$97.5M
-
Put/Call ratio
-
0.83
-
Number of buys
-
69
-
Number of sells
-
-83
-
Price
-
$17.31
Significant Holders of Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) as of Q1 2025
208 filings reported holding GPCR - Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value as of Q1 2025.
Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) has 150 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.9M shares
of 173M outstanding shares and own 32.37% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (7.79M shares), FMR LLC (5.88M shares), JANUS HENDERSON GROUP PLC (4.36M shares), Deep Track Capital, LP (4.1M shares), Capital Research Global Investors (2.16M shares), Vestal Point Capital, LP (1.79M shares), BVF INC/IL (1.77M shares), Capital International Investors (1.62M shares), RA CAPITAL MANAGEMENT, L.P. (1.52M shares), and AMERIPRISE FINANCIAL INC (1.48M shares).
This table shows the top 150 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.